Doris Guenzi Coit

This inventor holds 28 USPTO granted patents and 4 published patent applications, plus 5 CIPO patents and 6 EPO patents, primarily in Viral Immunology. Top assignees: Novartis Vaccines & Diagnostics, Gmbh, Chiron Corporation, Novartis Ag. Active years: 2002-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Doris Guenzi Coit. Retrieved from https://idiyas.com/inventor/doris-guenzi-coit

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 4)

% Patents Active = 75.0

CIPO Patents = 5

EPO Patents = 6 (Patent Applications = 5)

Average Co-Inventor Count = 5.5

ph-index = 8

Forward Citations = 201(Granted Patents)

Location History:

Emeryville, CA (US) (2009 - 2019)
Petaluma, CA (US) (2002 - 2020)

Company Filing History:

13 out of 245

Novartis Vaccines & Diagnostics, Gmbh

Ortho-Clinical Diagnostics, Inc

patents

5. 1 out of 30

Grifols Worldwide Operations Limited

where one patent can have more than one assignee

Years Active: 2002-2020

Loading Chart...

Areas of Expertise:

HCV Polypeptides

Norovirus Compositions

Immunogenic Reagents

Viral Antigens

Virus-Like Particles

Fusion Antigens

Immunoassays

GSK3 Polypeptides

Polynucleotides

HCV Antibody Assays

Sapovirus Antigens

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10753939 - HCV NS4a/modified NS3 polypeptides and uses thereof (2020-08-25),

2. 10287324 - Norovirus derived immunogenic compositions and methods (2019-05-14),

3. 10267803 - HCV NS4A/modified NS3 polypeptides and uses thereof (2019-04-23),

4. 10065994 - Norovirus derived immunogenic compositions and methods (2018-09-04),

5. 9744228 - Method for generating a parvovirus B19 virus-like particle (2017-08-29),

6. 9428739 - Norovirus and Sapovirus antigens (2016-08-30),

7. 8475808 - Immunogenic reagents from west nile virus (2013-07-02),

8. 8216590 - HCV fusion polypeptides (2012-07-10),

9. 8142793 - Norovirus and Sapovirus antigens (2012-03-27),

10. 8124104 - Norovirus and sapovirus antigens (2012-02-28),

11. 8119145 - Methods for producing norovirus VLPS (2012-02-21),

12. 7888004 - HCV non-structural polypeptide (2011-02-15),

13. 7871625 - HCV multiple epitope fusion antigens with modified proteolytic cleavage sites and uses thereof (2011-01-18),

14. 7807430 - GSK3 polypeptides (2010-10-05),

15. 7527801 - Norovirus and Sapovirus antigens (2009-05-05),

Title: Doris Guenzi Coit - Pioneering Inventor from Petaluma

Introduction: Doris Guenzi Coit is a trailblazing inventor hailing from Petaluma, California. Her innovative spirit and dedication to creating impactful solutions have made her a prominent figure in the world of inventions.

Latest Patents: Doris Guenzi Coit's latest patents focus on sustainable technologies for renewable energy sources and eco-friendly materials. Her inventions aim to address pressing environmental challenges and promote a greener future for generations to come.

Career Highlights: Throughout her illustrious career, Doris Guenzi Coit has received numerous accolades for her groundbreaking inventions. Her contributions to the field of sustainable technology have earned her recognition as a visionary inventor with a passion for creating positive change.

Collaborations: Doris Guenzi Coit has collaborated with leading research institutions and universities to further develop her innovative ideas. Her partnerships with experts in various fields have resulted in cutting-edge inventions that have the potential to revolutionize industries.

Conclusion: Doris Guenzi Coit's remarkable journey as an inventor showcases her unwavering commitment to driving progress through innovation. Her pioneering spirit and dedication to creating a more sustainable world continue to inspire inventors and entrepreneurs worldwide.

Profile summary based on public USPTO records.